That’s the message from BIO President & CEO Jim Greenwood in an op-ed for the Milken Institute about why we need to support America’s life sciences industry right now.
We all must do our part to protect our colleagues and slow the transmission of this deadly virus – just like Merck’s Dr. Ali is doing in London.
At the same time, the world is looking to biotech’s scientists and researchers to develop the diagnostics, treatments, and vaccines urgently needed to eradicate COVID-19, says Jim.
BIO is ensuring our industry has the resources, tools, and best practices it needs to move forward as safely as possible:
And while it’s all-hands-on-deck to tackle COVID-19, we also remain steadfast in our commitment to research and develop new medicines to prevent, treat, and cure disease in all forms, he explains.
Jim’s Judgment: In these trying times, the public is counting on America’s brilliant and dedicated researchers to discover new treatments that will stop the spread of the novel coronavirus and treat those who have been affected. On behalf of the men and women we represent, both the biopharmaceutical industry and BIO accept the challenge, and we won’t rest until this global health threat is eradicated. – BIO President & CEO Jim Greenwood
Read the op-edon the Milken Institute's website—and share on social media, tagging @IAmBiotech and @JimGreenwood.
More Health Care News:
Axios: Coronavirus vaccines could be ready sooner than expected, says Dr. Fauci
“Anthony Fauci told CBS News Wednesday it's ‘possible to shave a couple of months off’ his earlier projection that it would take 12-18 months until a novel coronavirus vaccine would be widely available. But he cautioned he didn't want to over-promise and it's ‘premature’ to discuss vaccine trials' data ‘except to say there have been no glitches.’”
STAT: Scientists tap CRISPR’s search-and-detect skills to create a rapid COVID-19 test
“The test takes roughly 40 minutes, compared with four to six hours for traditional PCR-based COVID-19 tests, which are currently being used. But the test also appears to produce false-negatives slightly more often than existing coronavirus tests.”
The Washington Post: Chaotic search for coronavirus treatments undermines efforts, experts say
“Researchers working around-the-clock describe a lack of a centralized national strategy, overlapping efforts, an array of small-scale trials that will not lead to definitive answers and no standards for how to prioritize efforts, what data to collect or how to share it to get to answers faster.”